Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial–mesenchymal transition via NF-κB signaling-Reference-Cited by-同舟云学术

Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial–mesenchymal transition via NF-κB signaling

Published:2014-04 Issue:3 Volume:116 Page:527-533
ISSN:0065-1281
Container-title:Acta Histochemica
language:en
Short-container-title:Acta Histochemica

Author:

Yan Zhaopeng,Yin Hongzhuan,Wang Rui,Wu Di,Sun Wei,Liu Baolin,Su Qi

Publisher

Elsevier BV

Subject

Cell Biology,Histology,General Medicine

Reference33 articles.

1. Chemoradiotherapy for colorectal cancer;Andre;Gut,2005

2. Tumor environment: a potent driving force in colorectal cancer?;Barker;Trends Mol Med,2001

3. Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models;Becker-Santos;Carcinogenesis,2012

4. Invasion and metastasis in colorectal cancer: epithelial–mesenchymal transition, mesenchymal–epithelial transition, stem cells and beta-catenin;Brabletz;Cells Tissues Organs,2005

5. ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway;Bravou;J Pathol,2006

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Receptor Tyrosine Kinase EphA2 and Integrin-linked Kinase Expression in Colorectal Cancer in Relation to the Severity of the Tumor;Medical Journal of Babylon;2024-06

2. Cancer spreading patterns based on epithelial-mesenchymal plasticity;Frontiers in Cell and Developmental Biology;2024-04-11

3. Exploring the promising potential of noscapine for cancer and neurodegenerative disease therapy through inhibition of integrin-linked kinase-1;International Journal of Biological Macromolecules;2024-03

4. Coiled‐coil domain containing 25 (CCDC25) regulates cell proliferation, migration, and invasion in clear cell renal cell carcinoma by targeting the ILK‐NF‐κB signaling pathway;The FASEB Journal;2024-01-18

5. Pharmacological targeting of MTHFD2 suppresses NSCLC via the regulation of ILK signaling pathway;Biomedicine & Pharmacotherapy;2023-05